SCHEMBL3156223

SCHEMBL3156223

CC(=O)NCCNc1cc(NC(=O)C(=O)N2CCN(c3ccccc3O)CC2)nc(-c2ccccc2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ ADORA2A P29274 3/20 0.41
▸ ADORA1 P30542 3/20 0.41
▸ ADORA2B P29275 3/20 0.41
▸ ADORA3 P0DMS8 2/20 0.41
▸ GAA P10253 5/20 0.40
▸ POLB P06746 2/20 0.40
▸ MEN1 O00255 3/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ ALOX15 P16050 1/20 0.38
▸ LMNA P02545 2/20 0.38
▸ MAPT P10636 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ CLK4 Q9HAZ1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3164424 0.91 ADORA2A (0.41) KMT2AADORA2AADORA1ADORA2BADORA3
SCHEMBL3170204 0.90 KMT2A (0.43) KMT2AADORA2AADORA1ADORA2BADORA3
SCHEMBL3166495 0.89 SLC1A2 (0.44) KMT2AADORA2AADORA1ADORA2BADORA3
SCHEMBL3162937 0.89 ADORA2A (0.46) ADORA2AADORA1ADORA2BADORA3ALOX15
SCHEMBL3165360 0.89 PHGDH (0.43) ADORA2AADORA1ADORA2BADORA3ALOX15
SCHEMBL3175820 0.89 MEN1 (0.46) KMT2APOLBMEN1MAPTALDH1A1
SCHEMBL3175769 0.88 ADORA2A (0.45) ADORA2AADORA1ADORA2BADORA3ALOX15
SCHEMBL3174594 0.88 ADORA2A (0.45) ADORA2AADORA1ADORA2BADORA3ALOX15
SCHEMBL3166225 0.88 ADORA2A (0.45) ADORA2AADORA1ADORA2BADORA3ALOX15
SCHEMBL3170498 0.87 TSHR (0.41) KMT2AADORA2AADORA1ADORA2BADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback